Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Senores Pharma acquires 75% stake in Apnar Pharma

PRIVATEAug 30, 2026•5 days ago

Acquiring Company

Senores Pharmaceuticals

Acquired Company

Apnar Pharmaceuticals

CopenhagenBahamasManufacturingBiotechnologyPharmaceuticalManufacturingBiotechnologyHealth CarePharmaceutical

Description

Senores Pharmaceuticals has completed Phase 1 of the acquisition of a 75% equity stake in Apnar Pharmaceuticals. This strategic acquisition aims to strengthen Senores' footprint in the pharmaceutical sector. The move reflects the company's commitment to expanding its product pipeline and market access. With this acquisition, Senores Pharmaceuticals is poised for further growth in both regulated and emerging markets.

Company Information

Company

Senores Pharmaceuticals

Location

Copenhagen, Capital Region Of Denmark, Denmark

About

Senores Pharmaceuticals is a global, research-driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for the US, Canada, and other regulated and emerging markets across various therapeutic areas and dosage forms.

Don't miss Senores Pharmaceuticals's next move

Get an email the moment Senores Pharmaceuticals makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for Senores Pharmaceuticals's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Apnar Pharmaceuticals?

Apnar Pharmaceuticals was acquired by Senores Pharmaceuticals, based in Copenhagen. The deal was reported on August 30, 2026. Senores Pharmaceuticals is privately held and operates in Manufacturing.

When did Senores Pharmaceuticals acquire Apnar Pharmaceuticals?

Senores Pharmaceuticals's acquisition of Apnar Pharmaceuticals was reported on August 30, 2026. Senores Pharmaceuticals has completed Phase 1 of the acquisition of a 75% equity stake in Apnar Pharmaceuticals. This strategic acquisition aims to strengthen Senores' footprint in the pharmaceutical sector. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Apnar Pharmaceuticals do?

Apnar Pharmaceuticals is a pharmaceutical company known for its contributions to the healthcare sector. The company specializes in developing a variety of generic medications across multiple therapeutic areas. It is privately held, operating in Manufacturing, and is based in Bahamas.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.